Today: 9 June 2026
Browse Category

NSE:DRREDDY 24 December 2025 - 22 January 2026

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

Sensex rose 0.49% and Nifty 50 gained 0.53% on Thursday, ending a three-day decline after U.S. President Trump eased tariff threats. The rupee closed at 91.63 per dollar, rebounding from a record low. Dr Reddy’s surged 5.2% after regulatory approval for a generic Ozempic, while Eternal fell 2.7%. The Reserve Bank of India conducted over $2 billion in FX swaps to support liquidity.
22 January 2026
··
India stock market today: Sensex, Nifty end lower as tariff jitters return; Reliance drags

India stock market today: Sensex, Nifty end lower as tariff jitters return; Reliance drags

The Sensex fell 0.30% to 83,627.69 and the Nifty 50 slipped 0.22% after a volatile session Tuesday, with Reliance and L&T among top drags. ONGC and Tech Mahindra led gainers. Foreign investors have sold $1.72 billion in Indian stocks so far in January. The rupee closed at 90.19 per dollar, slightly weaker, as the market eyed India-U.S. trade signals and upcoming earnings.
13 January 2026
·········
Top Stocks to Buy Today in India: ITC, Tata Steel, Dr Reddy’s, Coal India, Ajanta Pharma and More (24 December 2025)

Top Stocks to Buy Today in India: ITC, Tata Steel, Dr Reddy’s, Coal India, Ajanta Pharma and More (24 December 2025)

Indian equities slipped into the red by late afternoon Wednesday, with the Nifty 50 near 26,200 and the Sensex around 85,600 as IT and pharma stocks dragged. Early gains from strong US growth data faded amid cautious trading and thin holiday volumes. RBI’s planned liquidity injection and US visa policy changes weighed on sentiment. Technical analysts flagged Nifty support at 26,050 and resistance near 26,300.
24 December 2025
·····

Stock Market Today

  • Eli Lilly Shares Rise Premarket on Successful Late-Stage Weight Loss Trial
    June 8, 2026, 7:25 PM EDT. Eli Lilly's shares rose in premarket trading following positive results from a late-stage trial of retatrutide, a drug designed for weight loss. The trial demonstrated the drug's effectiveness not only in reducing weight but also in alleviating conditions linked to obesity, highlighting potential new treatment options in the growing obesity market.

Latest articles

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Peso Rebounds, But Mexico’s Next Inflation Print Looms

Peso Rebounds, But Mexico’s Next Inflation Print Looms

9 June 2026
Mexico’s peso edged up 0.09% to 17.4644 per dollar after Iran and Israel paused attacks, but traders turned cautious ahead of Tuesday’s Mexico inflation data, which could shape Banxico rate expectations and impact the peso’s yield advantage that has supported the currency.
T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
Go toTop